BACKGROUND: Solid organ transplant patients are theoretically at increased risk for complications after total joint replacement due to immunosuppressive medication regimens and multiple medical co-morbidities. There are a number of studies that report on outcomes of total joint arthroplasty (TJA) following solid organ transplant, however, the results are heterogeneous. This study evaluated the outcomes of TJA in solid organ transplant patients as compared to non-organ transplant controls at one academic medical center. METHODS: This study was a single institution retrospective review of a consecutive series of patients who underwent joint replacement following solid organ transplant as compared to a control cohort over a 10-year period. Univariable and multivariable generalized linear mixed effects models were used to compare the odds of readmission, infection, mortality, and being discharged home between transplanted (cases) and non-transplanted (control) patients. RESULTS: Transplant and non-transplant cohorts had similar BMI, although transplant patients were younger (61 versus 65 years) and had a higher incidence of Diabetes (55% vs. 16%). On multivariable analysis, there was no difference in the odds of re-admission or rate of infection, but there was an increased risk of death and admission to a rehab facility in the transplant cohort. CONCLUSION: Overall, this study demonstrates that solid organ transplant alone does not increase the risk of peri-operative complications in patients who underwent hip and knee replacement. However, it should be expected that these patients have a higher mortality rate and that many of them will need to be discharged to a post-acute care facility.
BACKGROUND: Solid organ transplant patients are theoretically at increased risk for complications after total joint replacement due to immunosuppressive medication regimens and multiple medical co-morbidities. There are a number of studies that report on outcomes of total joint arthroplasty (TJA) following solid organ transplant, however, the results are heterogeneous. This study evaluated the outcomes of TJA in solid organ transplant patients as compared to non-organ transplant controls at one academic medical center. METHODS: This study was a single institution retrospective review of a consecutive series of patients who underwent joint replacement following solid organ transplant as compared to a control cohort over a 10-year period. Univariable and multivariable generalized linear mixed effects models were used to compare the odds of readmission, infection, mortality, and being discharged home between transplanted (cases) and non-transplanted (control) patients. RESULTS: Transplant and non-transplant cohorts had similar BMI, although transplant patients were younger (61 versus 65 years) and had a higher incidence of Diabetes (55% vs. 16%). On multivariable analysis, there was no difference in the odds of re-admission or rate of infection, but there was an increased risk of death and admission to a rehab facility in the transplant cohort. CONCLUSION: Overall, this study demonstrates that solid organ transplant alone does not increase the risk of peri-operative complications in patients who underwent hip and knee replacement. However, it should be expected that these patients have a higher mortality rate and that many of them will need to be discharged to a post-acute care facility.
Authors: A Moreno; C Cervera; J Gavaldá; M Rovira; R de la Cámara; I Jarque; M Montejo; J de la Torre-Cisneros; J Miguel Cisneros; J Fortún; F López-Medrano; M Gurguí; P Muñoz; A Ramos; J Carratalá Journal: Am J Transplant Date: 2007-09-14 Impact factor: 8.086
Authors: Cameron K Ledford; Joseph M Statz; Brian P Chalmers; Kevin I Perry; Arlen D Hanssen; Matthew P Abdel Journal: J Arthroplasty Date: 2016-12-11 Impact factor: 4.757
Authors: C Trautwein; M Possienke; H J Schlitt; K H Böker; R Horn; R Raab; M P Manns; G Brabant Journal: Am J Gastroenterol Date: 2000-09 Impact factor: 10.864
Authors: Cameron K Ledford; Brian P Chalmers; Joseph M Statz; Kevin I Perry; Tad M Mabry; Arlen D Hanssen; Matthew P Abdel Journal: J Arthroplasty Date: 2016-07-25 Impact factor: 4.757
Authors: Sergio A Acuna; Kimberly A Fernandes; Corinne Daly; Lisa K Hicks; Rinku Sutradhar; S Joseph Kim; Nancy N Baxter Journal: JAMA Oncol Date: 2016-04 Impact factor: 31.777
Authors: H Hedri; M Cherif; K Zouaghi; E Abderrahim; R Goucha; F Ben Hamida; T Ben Abdallah; F Elyounsi; F Ben Moussa; H Ben Maiz; A Kheder Journal: Transplant Proc Date: 2007-05 Impact factor: 1.066
Authors: Lucas E Nikkel; Christopher S Hollenbeak; Edward J Fox; Tadahiro Uemura; Nasrollah Ghahramani Journal: Transplantation Date: 2009-06-27 Impact factor: 4.939
Authors: Christine J Wu; Adam C Brekke; Zoe W Hinton; Billy I Kim; Sean P Ryan; Michael P Bolognesi; Thorsten M Seyler Journal: Int Orthop Date: 2022-10-12 Impact factor: 3.479
Authors: Alex Upfill-Brown; Christopher M Hart; Peter P Hsiue; Kadarius Burgess; Clark J Chen; Amir Khoshbin; Christos Photopoulos; Alexandra I Stavrakis Journal: Arthroplast Today Date: 2022-01-20